These results indicate that ATRA induced the overexpression of RARα and reduced the expression of MMP2, MMP9, and AT1 in the AAA group, which suggests that ATRA maintains vascular integrity through RARα and plays a negative regulatory role in AAA. The gene discussed is MMP2; the disease is triple-A syndrome.